Cooling down VITT with IVIG.
作者信息
Lentz Steven R
机构信息
University of Iowa.
出版信息
Blood. 2021 Sep 16;138(11):921-922. doi: 10.1182/blood.2021012819.
Abstract
摘要
相似文献
1
Cooling down VITT with IVIG.用静脉注射免疫球蛋白使疫苗诱导的血栓性血小板减少症降温。
Blood. 2021 Sep 16;138(11):921-922. doi: 10.1182/blood.2021012819.
2
Mechanisms of IVIG action in immune thrombocytopenic purpura.静脉注射免疫球蛋白在免疫性血小板减少性紫癜中的作用机制。
Clin Lab. 2004;50(3-4):133-40.
3
The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.不同剂量静脉注射免疫球蛋白治疗急性特发性血小板减少性紫癜的疗效：13项随机对照试验的荟萃分析
Blood Coagul Fibrinolysis. 2010 Dec;21(8):713-21. doi: 10.1097/MBC.0b013e3283401490.
4
5
Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.静脉注射免疫球蛋白在免疫性血小板减少性紫癜中的作用机制。
Hum Immunol. 2005 Apr;66(4):403-10. doi: 10.1016/j.humimm.2005.01.029.
6
Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.加拿大关于静脉注射免疫球蛋白治疗儿童急性特发性血小板减少性紫癜的成本效用分析。
J Popul Ther Clin Pharmacol. 2012;19(2):e166-78. Epub 2012 May 1.
7
Treatment of steroid-resistant idiopathic thrombocytopenic purpura in pregnancy with repeated high-dose intravenous immunoglobulin.
Haematologia (Budap). 2001;31(3):263-5. doi: 10.1163/15685590152763827.
8
Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.静脉注射免疫球蛋白与静脉注射抗-D免疫球蛋白治疗急性免疫性血小板减少性紫癜的比较
Indian J Pediatr. 2008 Dec;75(12):1231-5. doi: 10.1007/s12098-008-0243-y. Epub 2009 Feb 4.
9
Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.Fcγ受体在特发性血小板减少性紫癜发病机制及治疗中的作用
J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S14-8. doi: 10.1097/00043426-200312001-00004.
10
Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review.静脉注射免疫球蛋白相关的急性冠状动脉综合征与特发性血小板减少性紫癜的冠状动脉造影——一例报告及文献复习
Angiology. 2002 Jan-Feb;53(1):113-7. doi: 10.1177/000331970205300117.
引用本文的文献
1
Intravenous immunoglobulin ameliorates doxorubicin-induced intestinal mucositis by inhibiting the Syk/PI3K/Akt axis and ferroptosis.静脉注射免疫球蛋白通过抑制Syk/PI3K/Akt轴和铁死亡来改善阿霉素诱导的肠道粘膜炎。
Apoptosis. 2025 Apr;30(3-4):734-750. doi: 10.1007/s10495-024-02064-y. Epub 2024 Dec 25.
2
Lower limb arterial thrombosis followed by sub-massive pulmonary thromboembolism after Sinopharm BBIBP-CorV COVID-19 vaccination.接种国药集团北京生物制品研究所有限责任公司的新型冠状病毒灭活疫苗（Vero细胞）后发生下肢动脉血栓形成并继发次大面积肺血栓栓塞症
Arch Clin Cases. 2022 Dec 19;9(4):150-153. doi: 10.22551/2022.37.0904.10222. eCollection 2022.
3
Platelet in thrombo-inflammation: Unraveling new therapeutic targets.血小板在血栓炎症中的作用：揭示新的治疗靶点。
Front Immunol. 2022 Nov 14;13:1039843. doi: 10.3389/fimmu.2022.1039843. eCollection 2022.
4
Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的治疗。
Semin Hematol. 2022 Apr;59(2):89-96. doi: 10.1053/j.seminhematol.2022.03.002. Epub 2022 Mar 7.
5
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.新型冠状病毒肺炎及疫苗诱导的免疫性血栓性血小板减少症中的免疫介导血小板激活
Front Immunol. 2022 Feb 22;13:837629. doi: 10.3389/fimmu.2022.837629. eCollection 2022.
6
VITT(al) insights into vaccine-related clots.关于疫苗相关血栓的重要见解。
Blood. 2021 Dec 2;138(22):2159-2160. doi: 10.1182/blood.2021014195.
本文引用的文献
1
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia.静脉注射免疫球蛋白在疫苗诱导的免疫性血栓性血小板减少症治疗中的应用。
Blood. 2021 Sep 16;138(11):992-996. doi: 10.1182/blood.2021012479.
2
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia.抗体介导的 SARS-CoV-2 疫苗接种相关免疫性血栓性血小板减少症中的促凝血小板。
Haematologica. 2021 Aug 1;106(8):2170-2179. doi: 10.3324/haematol.2021.279000.
3
Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.评价 ChAdOx1 nCOV-19 疫苗接种后抗血小板因子 4 抗体的实验室检测。
J Thromb Haemost. 2021 Aug;19(8):2007-2013. doi: 10.1111/jth.15362. Epub 2021 Jul 5.
4
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
5
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.接种 ChAdOx1 nCoV-19 疫苗后对血小板因子 4 的病理性抗体。
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.
6
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
7
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
8
Autoimmune heparin-induced thrombocytopenia.自身免疫性肝素诱导的血小板减少症。
J Thromb Haemost. 2017 Nov;15(11):2099-2114. doi: 10.1111/jth.13813. Epub 2017 Sep 28.
Zotero 插件